Home/Pipeline/MeMed Key

MeMed Key

Platform for Multiplex Protein Measurement

CommercialAvailable

Key Facts

Indication
Platform for Multiplex Protein Measurement
Phase
Commercial
Status
Available
Company

About MeMed

MeMed delivers FDA‑cleared, 15‑minute host‑immune response tests that differentiate bacterial and viral infections, supporting better clinical decisions.

View full company profile